1. Home
  2. FUSB vs GANX Comparison

FUSB vs GANX Comparison

Compare FUSB & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUSB
  • GANX
  • Stock Information
  • Founded
  • FUSB 1952
  • GANX 2017
  • Country
  • FUSB United States
  • GANX United States
  • Employees
  • FUSB N/A
  • GANX N/A
  • Industry
  • FUSB Major Banks
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUSB Finance
  • GANX Health Care
  • Exchange
  • FUSB Nasdaq
  • GANX Nasdaq
  • Market Cap
  • FUSB 69.3M
  • GANX 69.0M
  • IPO Year
  • FUSB N/A
  • GANX 2021
  • Fundamental
  • Price
  • FUSB $12.00
  • GANX $1.66
  • Analyst Decision
  • FUSB
  • GANX Strong Buy
  • Analyst Count
  • FUSB 0
  • GANX 5
  • Target Price
  • FUSB N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • FUSB 3.9K
  • GANX 599.4K
  • Earning Date
  • FUSB 10-23-2025
  • GANX 08-12-2025
  • Dividend Yield
  • FUSB 2.33%
  • GANX N/A
  • EPS Growth
  • FUSB N/A
  • GANX N/A
  • EPS
  • FUSB 0.97
  • GANX N/A
  • Revenue
  • FUSB $36,046,000.00
  • GANX N/A
  • Revenue This Year
  • FUSB N/A
  • GANX N/A
  • Revenue Next Year
  • FUSB N/A
  • GANX N/A
  • P/E Ratio
  • FUSB $12.08
  • GANX N/A
  • Revenue Growth
  • FUSB N/A
  • GANX N/A
  • 52 Week Low
  • FUSB $10.30
  • GANX $1.36
  • 52 Week High
  • FUSB $14.30
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • FUSB 50.32
  • GANX 44.47
  • Support Level
  • FUSB $11.00
  • GANX $1.55
  • Resistance Level
  • FUSB $12.22
  • GANX $1.78
  • Average True Range (ATR)
  • FUSB 0.57
  • GANX 0.14
  • MACD
  • FUSB 0.07
  • GANX -0.03
  • Stochastic Oscillator
  • FUSB 61.98
  • GANX 21.15

About FUSB First US Bancshares Inc.

First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: